Kristen L. Wells

Dr. Kristen L. Wells

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2018 in Nature
Verified
Journal Article
Closed access
PDF file
CMCorey N. Miller
Corey N. Miller
IPIrina Proekt
Irina Proekt
JMJakob von Moltke
Jakob von Moltke
KWKristen L. Wells
Kristen L. Wells
ARAparna R. Rajpurkar
Aparna R. Rajpurkar
MAMark S. Anderson
Mark S. Anderson

23 November 2020 in eLife
Verified
Journal Article
Open access
KWKristen L. Wells
Kristen L. Wells
CMCorey N Miller
Corey N Miller
AGAndreas R Gschwind
Andreas R Gschwind
WWWu Wei
Wu Wei
JPJonah D Phipps
Jonah D Phipps
LSLars M Steinmetz
Lars M Steinmetz
Medullary thymic epithelial cells (mTECs) play a critical role in central immune tolerance by mediating negative selection of autoreactive T cells through the collective expression of the peripheral self-antigen compartment, including tissue-specific antigens (TSAs). Recent work has shown that gene-expression patterns within the mTEC compartment are heterogenous and include multiple differentiated cell states. To further define mTEC development and medullary epithelial lineage relationships, we combined lineage tracing and recovery from transient in vivo mTEC ablation with single-cell RNA-sequencing in Mus musculus. The combination of bioinformatic and experimental approaches revealed a non-stem transit-amplifying population of cycling mTECs that preceded Aire expression. We propose a branching model of mTEC development wherein a heterogeneous pool of transit-amplifying cells gives rise to Aire- and Ccl21a-expressing mTEC subsets. We further use experimental techniques to show that within the Aire-expressing developmental branch, TSA expression peaked as Aire expression decreased, implying Aire expression must be established before TSA expression can occur. Collectively, these data provide a roadmap of mTEC development and demonstrate the power of combinatorial approaches leveraging both in vivo models and high-dimensional datasets.

20 September 2023 in Nature
Verified
Journal Article
Open access
PDF file
FYFeng Yuan
Feng Yuan
GGGrace N. Gasser
Grace N. Gasser
ELEvan Lemire
Evan Lemire
DMDaniel T. Montoro
Daniel T. Montoro
KJKarthik Jagadeesh
Karthik Jagadeesh
JEJohn Engelhardt
John Engelhardt
Speciation leads to adaptive changes in organ cellular physiology and creates challenges for studying rare cell-type functions that diverge between humans and mice. Rare cystic fibrosis transmembrane conductance regulator (CFTR)-rich pulmonary ionocytes exist throughout the cartilaginous airways of humans1,2, but limited presence and divergent biology in the proximal trachea of mice has prevented the use of traditional transgenic models to elucidate ionocyte functions in the airway. Here we describe the creation and use of conditional genetic ferret models to dissect pulmonary ionocyte biology and function by enabling ionocyte lineage tracing (FOXI1-CreERT2::ROSA-TG), ionocyte ablation (FOXI1-KO) and ionocyte-specific deletion of CFTR (FOXI1-CreERT2::CFTRL/L). By comparing these models with cystic fibrosis ferrets3,4, we demonstrate that ionocytes control airway surface liquid absorption, secretion, pH and mucus viscosity—leading to reduced airway surface liquid volume and impaired mucociliary clearance in cystic fibrosis, FOXI1-KO and FOXI1-CreERT2::CFTRL/L ferrets. These processes are regulated by CFTR-dependent ionocyte transport of Cl− and HCO3−. Single-cell transcriptomics and in vivo lineage tracing revealed three subtypes of pulmonary ionocytes and a FOXI1-lineage common rare cell progenitor for ionocytes, tuft cells and neuroendocrine cells during airway development. Thus, rare pulmonary ionocytes perform critical CFTR-dependent functions in the proximal airway that are hallmark features of cystic fibrosis airway disease. These studies provide a road map for using conditional genetics in the first non-rodent mammal to address gene function, cell biology and disease processes that have greater evolutionary conservation between humans and ferrets.

8 October 2021 in Science Immunology
Verified
Journal Article
Closed access
HKHamish W. King
Hamish W. King
KWKristen L. Wells
Kristen L. Wells
ZSZohar Shipony
Zohar Shipony
AKArwa S. Kathiria
Arwa S. Kathiria
LWLisa E. Wagar
Lisa E. Wagar
WGWilliam J. Greenleaf
William J. Greenleaf
Single-cell ATAC sequencing maps the cell type–specific regulatory potential of transcription factors and autoimmune disease risk loci.

15 May 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZSZachary C. Stensland
Zachary C. Stensland
CMChristopher A. Magera
Christopher A. Magera
HBHali Broncucia
Hali Broncucia
BGBrittany D. Gomez
Brittany D. Gomez
NRNasha M. Rios-Guzman
Nasha M. Rios-Guzman
MSMia Smith
Mia Smith
Recent evidence suggests a role for B cells in the pathogenesis of young-onset type 1 diabetes (T1D), wherein rapid progression occurs. However, little is known regarding the specificity, phenotype, and function of B cells in young-onset T1D. We performed a cross-sectional analysis comparing insulin-reactive to tetanus-reactive B cells in the blood of T1D and controls using mass cytometry. Unsupervised clustering revealed the existence of a highly activated B cell subset we term BND2 that falls within the previously defined anergic BND subset. We found a specific increase in the frequency of insulin-reactive BND2 cells in the blood of young-onset T1D donors, which was further enriched in the pancreatic lymph nodes of T1D donors. The frequency of insulin-binding BND2 cells correlated with anti-insulin autoantibody levels. We demonstrate BND2 cells are pre-plasma cells and can likely act as APCs to T cells. These findings identify an antigen-specific B cell subset that may play a role in the rapid progression of young-onset T1D.

25 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
NMNicole D. Moss
Nicole D. Moss
KWKristen L. Wells
Kristen L. Wells
ATAlexandra Theis
Alexandra Theis
YKYoung-Kyung Kim
Young-Kyung Kim
ASAliya F. Spigelman
Aliya F. Spigelman
LSLori Sussel
Lori Sussel
Insulin secretion is a tightly regulated process that is vital for maintaining blood glucose homeostasis. Although the molecular components of insulin granule trafficking and secretion are well established, how they are regulated to rapidly fine-tune secretion in response to changing environmental conditions is not well characterized. Recent studies have determined that dysregulation of RNA-binding proteins (RBPs) and aberrant mRNA splicing occurs at the onset of diabetes. We demonstrate that the RBP, RBFOX2, is a critical regulator of insulin secretion through the alternative splicing of genes required for insulin granule docking and exocytosis. Conditional mutation of Rbfox2 in the mouse pancreas results in decreased insulin secretion and impaired blood glucose homeostasis. Consistent with defects in secretion, we observe reduced insulin granule docking and corresponding splicing defects in the SNARE complex components. These findings identify an additional mechanism for modulating insulin secretion in both healthy and dysfunctional pancreatic β cells.